PET/CT has advantages for advanced breast cancer cases

January 4, 2013

A new study in the January issue of the Journal of Nuclear Medicine finds that 18F-FDG-PET/CT is successful in determining the prognostic stratification -- or the rate of death from cancer -- for patients with locally advanced breast cancer when compared to conventional imaging.

Researchers from the Department of Nuclear Medicine at Saint-Louis Hospital in Paris studied a cohort of 117 patients with locally advanced breast cancer over a five-year period. Conventional imaging studies, such as bone scans, chest X-rays, and dedicated CT, were compared to results from 18F-FDG-PET/CT scans. 18F-FDG PET/CT detected distant metastases in 43 patients; conventional imaging only identified 28 patients with distant metastases.